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Introduction: We wished to characterize the relationship of advanced age to clinical outcomes and to
transcriptomic responses after severe blunt traumatic injury with hemorrhagic shock.
Methods: We performed epidemiological, cytokine, and transcriptomic analyses on a prospective, multi-center
cohort of 1,928 severely injured patients.
Results: We found that there was no difference in injury severity between the aged (age ≥55, n = 533) and young
(age <55, n = 1395) cohorts. However, aged patients had more comorbidities. Advanced age was associated with
more severe organ failure, infectious complications, ventilator days, and intensive care unit length of stay, as well as,
an increased likelihood of being discharged to skilled nursing or long-term care facilities. Additionally, advanced
age was an independent predictor of a complicated recovery and 28-day mortality. Acutely after trauma, blood
neutrophil genome-wide expression analysis revealed an attenuated transcriptomic response as compared to the
young; this attenuated response was supported by the patients’ plasma cytokine and chemokine concentrations.
Later, these patients demonstrated gene expression changes consistent with simultaneous, persistent pro-inflammatory
and immunosuppressive states.
Conclusions: We concluded that advanced age is one of the strongest non-injury related risk factors for poor
outcomes after severe trauma with hemorrhagic shock and is associated with an altered and unique peripheral
leukocyte genomic response. As the general population’s age increases, it will be important to individualize
prediction models and therapeutic targets to this high risk cohort.Introduction
Severe traumatic injury is responsible for a major per-
centage of deaths worldwide [1] and elderly patients are
thought to have greater morbidity and mortality than
their younger counterparts [2]. Severely injured patients
who develop multiple organ failure (MOF) often demon-
strate a failure in protective immunity [3], and it is pre-
sumed that advanced age exacerbates these impairments* Correspondence: philip.efron@surgery.ufl.edu
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unless otherwise stated.in immune function [4]. However, there has been a lack
of concomitant epidemiologic and genomic data in eld-
erly injured patients to help elucidate these mechanisms
and determine their association with clinical outcomes.
The Inflammation and the Host Response to Injury
Collaborative Program Trauma Glue Grant (GG) was a
prospective, multi-institutional observational study with
the primary aims of describing the epidemiology, prote-
omic, and leukocyte genomic response in severely in-
jured burn and trauma patients [5]. The latter consisted
of patients who had suffered blunt trauma and who were
in hemorrhagic shock without evidence of severe trau-
matic brain injury (TBI). Analysis of total circulatingl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that a so-called genomic storm at the level of the
leukocyte transcriptome occurred after traumatic injury,
adding further human translational investigative support
to the fact that the systemic inflammatory response syn-
drome (SIRS) and compensatory anti-inflammatory re-
sponses (CARS) occurred simultaneously rather than
sequentially [6,7]. Patients who exhibited a complicated
clinical trajectory, defined as greater than fourteen days
of persistent organ dysfunction or death, had exacerba-
tion and prolongation of their transcriptomic response,
and failure to return to baseline expression patterns [6].
In addition, a rapid genomic composite score was devel-
oped, using 63 select genes, which determine within 12
to 24 hours of injury those patients who are destined to
have a complicated clinical trajectory [8,9].
Interestingly, recently published data by our group
utilizing murine models of infection and trauma do not
completely support this severely exacerbated gene ex-
pression pattern in mice of advanced age, although res-
toration of genomic homeostasis is certainly delayed
[10,11]. Although murine and human responses to in-
flammation are certainly not equivalent at the level of
the transcriptome [12], genomic expression patterns in
some individual pathways, such as innate immunity, can
be well-replicated in mice [13]. In addition, researchers
are performing translation data in humans that supports
these specific differences in inflammatory responses to
injury or infection in the elderly [14].
To date, genomic analyses in this severely injured pa-
tient cohort have been carried out primarily on total
leukocyte populations, rather than on isolated peripheral
polymorphonuclear neutrophils (PMNs), which are the
predominant circulating leukocytes after severe injury
[6]. In addition, the cohorts from these analyses con-
tained only patients <55 years old. Therefore, the goal of
this study was three-fold: (1) determine whether ad-
vanced age is associated with increased morbidity and
poor clinical outcomes both with standard measures of
outcome (that is, 28-day mortality), as well as more re-
cently proposed measures of long-term disposition; (2)
characterize the PMN genomic response after severe blunt
traumatic injury with hemorrhagic shock, and; (3) deter-
mine if the genomic storm identified in younger cohorts is
also seen in PMNs from the aged after trauma. We hy-
pothesized that advanced age would be associated with
worsened outcomes, and a unique genomic response in
severely injured patients with hemorrhagic shock.
Methods
Approval was obtained from the University of Florida
Institutional Review Board to analyze de-identified hu-
man data obtained from the GG Trauma Related Data-
base (TRDB) prior to initiation of this study [15]. Theclinical protocol and consent forms were reviewed and
approved by the central administration site at Massachu-
setts General Hospital (Institutional Review Board (IRB)
MGH Protocol # 2002P001743). In addition, the clinical
protocol was reviewed and approved by each of the
seven participating clinical sites. In every case, signed in-
formed consent was obtained from the individual patient
or their designated legal representative. If informed con-
sent was obtained from the legal representative, the pa-
tient was re-consented after they had achieved a clinical
state where they could provide informed consent. Based
on individual IRBs, the time period required to obtain
informed consent from the patient or legal representa-
tive varied from 24 hours to within hospitalization due
to the vulnerable nature of the patient and their legal
representatives. In all cases, the IRBs accepted the argu-
ment that patients and their families are often vulnerable
in the early post-trauma period, and require some time
period to adjust to the severity of the patient’s injury,
and provide informed consent.
Data source and cohort selection
The TRDB contains audited and de-identified data ob-
tained from severely injured trauma patients enrolled
from seven level-1 trauma centers between 2001 and
2011 [16]. Inclusion criteria included adult patients (age
≥16 years old), who had been severely injured (injury se-
verity score (ISS) >15) having undergone blunt trauma
without severe TBI, and with evidence of hemorrhagic
shock (systolic blood pressure (SBP) <90 mmHg or base
deficit ≥6 mEq/L, and requiring blood transfusion). In
order to address confounding by variations in treatment
strategies between centers, clinical standard operating
procedures (SOPs) were established and applied to all
enrolled patients. Compliance with application of these
SOPs was subjected to audit over the course of the study
[15,17].
As of October 2013, the TRDB contained detailed,
prospectively collected demographic, clinical, and out-
comes data on 1,928 patients with blunt trauma and in
hemorrhagic shock, who met the criteria for this ana-
lysis. These patients were separated into two main co-
horts, either advanced age (≥55 years old) or young (<55
years old) for epidemiologic analysis. The age of 55 years
was used as the cutoff for several reasons. First, the ini-
tial phase of the GG limited enrollment to those <55
years, which was later extended to include all patients
over the age of 16 and was used as the original age cut-
off by the GG to define the aged population [18]. Sec-
ond, studies by Demetriades and colleagues analyzing
the validity of the trauma and injury severity score
(TRISS) methodology and by Sauaia et al. looking at
early predictors of post injury MOF further supported
this cutoff. Both illustrated that being age 55 years or
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than predicted, even after controlling for other injury
factors [19,20]. Using these definitions for young and
aged, there were 1,395 and 533 patients in the young
and aged cohorts, respectively.
In addition to the trauma patients enrolled for epide-
miologic data collection in the TRDB, a subset of 244 se-
verely injured trauma patients, 16 to 90 years old, and
an additional 21 healthy controls were enrolled for blood
sampling for enriched PMN genomic analysis. When
separated based on age, there were 67 aged and 177
young trauma patients. The patients in the GG were also
classified based on clinical outcomes into complicated,
intermediate or uncomplicated cohorts. In this regard,
complicated outcomes were defined as either ICU
hospitalization longer than 14 days with evidence of on-
going organ dysfunction, or death [6,15]. Uncomplicated
outcomes were defined as those with organ recovery and
ICU hospitalization for <5 days. Those who fell between
these two classifications were considered intermediate.
Therefore, the patients were divided into four distinct
groups based on clinical outcomes (either complicated
or uncomplicated) and age as follows: complicated aged
(n = 25), uncomplicated aged (n = 8), complicated young
(n = 42) and uncomplicated young (n = 55).
Next, we attempted to remove confounding in these
cohorts due to gender or injury severity by creating
matched pairs based on gender, abbreviate injury scores
(AIS), as well as, the number and timing of the samples
obtained or the death of the patient. The gender of
healthy controls was matched to the cohort as closely as
possible. Unfortunately, no healthy controls older than
55 years were available. However, the transcriptomic
analysis of uncomplicated aged and young patients de-
termined that there was no detectable genomic differ-
ence between the two groups. Regardless, this resulted
in the creation of a much smaller subset for transcrip-
tomic analysis, which included 4 matched uncompli-
cated aged and young trauma pairs, as well as 17
matched complicated aged and young trauma pairs.
These were compared to 4 and 17 healthy control pa-
tients, respectively.
Clinical outcomes and multivariable logistic regression
analysis
Baseline patient demographics, injury severity, fluid and
blood product resuscitation parameters, serial laboratory
values and multiple clinical outcomes, including compli-
cated recovery and 28-day mortality, were obtained from
the TRDB. Ventilator-associated pneumonia (VAP) was
used rather than ventilator associated events (VAE), as
VAE had not been defined by the CDC at the time of
study initiation and was therefore not tracked in the
database. Univariate analyses were performed betweenyoung and aged cohorts using Fisher’s exact test and the
Wilcoxon two-sample test as appropriate.
To determine the role of age as an independent pre-
dictor of poor outcome, multivariate stepwise logistic re-
gression models were created using prior known and
suspected confounding risk factors, as well as any sig-
nificant predictive factors identified by univariate ana-
lysis. Patients who died within 48 hours of injury were
excluded from the complicated outcomes model in order
to remove confounding effects of death from irreversible
hemorrhagic shock or non-survivable injuries. All pa-
tients were included for 28-day mortality modeling. All
significance tests were two-sided, with a 0.05 alpha level.
Statistical analyses were performed with SAS (v.9.3,
Cary, NC, USA).
Gene expression profile analysis
Of the 1,928 trauma patients enrolled, 244 underwent
isolated PMN blood sampling, including aged (n = 67) and
young (n = 177) patients. In addition, there were 17 healthy
control samples from patients <55 years old. Patients
enrolled in the leukocyte subpopulation sampling portion
of the study had blood drawn within 12 hours of injury and
then subsequently at 1, 4, 7, 14, 21 and 28 days after injury
while hospitalized. Circulating PMNs were isolated by posi-
tive selection using microfluidic cassettes [21]. Ingenuity
System Analysis (IPA®) was used to perform genomic ana-
lysis among the trauma patients and healthy controls after
RNA extraction and hybridization onto proprietary HH1/2/3
GeneChips™ [22], manufactured by Affymetrix (Santa Clara,
CA, USA) specifically for the GG program [21,23].
Three separate analyses were performed as follows: (1)
all aged and young trauma patients compared to healthy
controls; (2) matched uncomplicated young and uncom-
plicated aged trauma-patient pairs compared to matched
controls; and (3) matched complicated young and com-
plicated aged trauma-patient pairs compared to matched
controls. Matching for the latter involved identifying
complicated patients from each age group who were the
same sex, had the same AIS, had the same number and
time point of sample isolation, and had both either sur-
vived or died by 28 days. For each of these sets, we iden-
tified significant trauma-responsive genes and the
difference in the genome-wide expression patterns over-
all, as well as differences at days 0.5, 1.0, and 4.0 days
after injury (P <0.001, F-test). Leave one out cross-
validation was performed to compute the misclassifica-
tion rate, and a Monte Carlo simulation was conducted
to test if the miscalculation rate was significantly better
than predicted by chance.
In addition, the datasets were analyzed for individual
gene expression differences (magnitude of fold change,
P <0.001), as well as for individual pathway (Gene
Ontology and Biocarta, distance from reference (DFR),
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Z-score (<-2, >2)). A Z-score <-2, or >2, represents a
significant change at a 95% CI [24].
A secondary analysis of isolated PMN expression using
the 63 trauma-responsive genes that had previously been
found to be predictive of complicated outcomes after se-
vere trauma [8] was performed and compared in a simi-
lar fashion as to above.
To quantify the overall perturbation in gene expres-
sion, a modified DFR metric was calculated based on
previously reported methodology using the equation. [9].
The DFR is a single natural logarithmic genomic score
that summates all the individual gene expression alter-
ations from baseline, whether up- or downregulated,
where ei is the patient’s expression level, and Mi and Vi
are the mean and variance of the control group for the
ith probe set. Thus, each patient’s overall altered tran-
scriptomic response can be represented by a single nat-
ural log-transformed metric, although it can also be
calculated without the natural log transformation as
well. The DFR values for analyzed patients were calcu-
lated without taking the natural log of the sums and the
results reported are reflective of this.
One-way analysis of variance (ANOVA), Newman-
Keul, Kruskal-Wallis, or Holm-Sidak multiple compari-
son tests were performed when appropriate, with a
0.05 alpha level unless indicated differently above. Gen-
omic statistical analyses were performed using GraphPad
Prism 6.00 (La Jolla, CA, USA).
Plasma cytokine and chemokine analysis
Patients who were enrolled in the leukocyte subpopula-
tion sampling also had plasma samples that were ob-
tained during the study period. Plasma samples were
collected within 12 hours of trauma onset, and at 1, 4, 7,
14, 21 and 28 days after injury, or up to the time of hos-
pital discharge if the patient was accessible. Analysis was
performed on the 17 matched young and aged trauma-
patient pairs with complicated outcomes, along with
controls, who were used for the gene expression analysis
mentioned previously.
Plasma samples were tested for the following analytes:
IL-6, IL-8, IL-10, IL-1β, Interferon gamma-induced protein
(IP)-10, Monocyte chemoattractant protein (MCP)-1 and
TNF-α, according to the manufacturer’s protocol, on the
Luminex MAGPIX® xMap system (Luminex, Austin, TX,
USA) using Milliplex® MAP multiplex kits (Millipore, Billerica,
MA, USA). The sample concentrations were then generated
with the Milliplex® Analyst 5.1 software using best-fit curves.
Two-way ANOVA and generation of general linear
models (GLMs) were used for comparison. Because the
number of samples in the two cohorts varied over time,
whether due to discharge or death over the study period,
GLMs were determined to be the appropriate methodfor comparison. They were used to examine whether the
significant differences seen in plasma cytokine/chemo-
kine concentrations were due to age and/or time after
injury and the results reported are from this analysis
(P <0.05, 95% CI). Statistical analysis was performed
using SAS (v.9.3, Cary, NC, USA).
The data obtained in the methods and discussed in this
publication have been deposited in a public repository, the
National Center for Biotechnology Information’s (NCBI)




Patient clinical characteristics, outcomes and multivariate
logistic regression model analysis
The overall cohort consisted of 1,928 severely injured pa-
tients in hemorrhagic shock. After dividing the population
into young (age <55 years) and aged (age ≥55 years) co-
horts, there was no significant difference between the
groups in injury severity or total amount of blood trans-
fused (Table 1). Aged patients had an increased number of
comorbid conditions at admission, as well as evidence of
more severe shock with lower initial SBP, increased lactate
levels and higher acute physiology and chronic health
evaluation (APACHE) II scores on admission as compared
to their younger counterparts (Table 1).
When comparing clinical outcomes among other risk
factors, age >55 years was associated with significantly
higher MOF scores, longer ICU length of stay (LOS), in-
creased ventilator days, and higher rates of both non-
infectious and infectious complications (Table 1). The
incidence of VAP and tracheostomy placement was sig-
nificantly elevated in patients of advanced age. In
addition, among other risk factors, age >55 years was as-
sociated with significantly higher rates of complicated
outcome and 28-day mortality (Table 1). Among those
patients who survived, the aged cohort was more likely
to be discharged to skilled nursing facilities or long-term
acute care facilities, rather than home or rehabilitation
facilities (Table 2).
Multivariate logistic regression analysis revealed that
age 55 years or older was a strong independent risk fac-
tor for the development of a complicated clinical out-
come (defined as either ICU hospitalization >14 days
with evidence of ongoing organ dysfunction, or death)
after controlling for injury severity, shock severity, blood
transfusion and comorbidities (Table 3). Similarly, ad-
vanced age was a strong independent risk factor for 28-
day mortality (Table 3).
Neutrophil microarray genomic analysis
Initial genomic analysis demonstrated that there was no
significant age-based difference in the transcriptomic
Table 1 Patient demographics and outcomes of patients with severe blunt trauma injury and hemorrhagic shock
Patient demographics and outcomes
Young (age <55 years) (n = 1,395) Aged (age ≥55 years) (n = 533)
Number (%) or median (IQR) P-value
Demographics
Age, years 34 (24 to 45) 66 (59 to 75)
Gender, male 954 (68%) 331 (62%) 0.010a
NISS 36 (27 to 48) 34 (27 to 48) 0.10
Body mass index, kg/m2 27 (24 to 31) 28 (25 to 32) <0.001a
Max Apache II score 0 to 24 hours 28 (24 to 32) 32 (27 to 37) <0.001a
Injury to ED arrival, hours 1.3 (0.7 to 2.3) 1.4 (0.8 to 2.9) 0.001a
Lowest ED SBP, mmHg 84 (72 to 98) 78 (66 to 88) <0.001a
Max lactate 12 to 24 hours, mmol/L 2.8 (2.0 to 4.3) 3.0 (2.1 to 4.5) 0.035a
Total blood 0 to 12 hours, U 4.6 (2.1 to 9.1) 5.0 (2.6 to 9.0) 0.83
Total crystalloid 0 to 12 hours, L 9.9 (7.0 to 14.0) 9.0 (6.1 to 12.7) <0.001a
Major acute surgical procedures 1,312 (94%) 475 (89%) <0.001a
Pre-existing comorbidities
Preexisting medications 563 (40%) 412 (77%) <0.001a
Major medical comorbidity, ≥1 813 (62.4%) 419 (87.1%) <0.001a
Hypertension 99 (7%) 214 (40%) <0.001a
Congestive heart failure 0 (0%) 0 (0%) -
Atrial arrhythmia 7 (0.5%) 31 (5.6%) <0.001a
Ventricular arrhythmia 1 (0.1%) 4 (0.8%) 0.009a
Peripheral vascular disease 7 (0.5%) 16 (3.0%) <0.001a
Cerebrovascular disease 9 (0.7%) 40 (7.5%) <0.001a
Dementia 0 (0%) 20 (3.8%) <0.001a
Obstructive pulmonary disease 64 (4.6%) 30 (5.6%) 0.35
Malignancy 23 (1.7%) 47 (8.8%) <0.001a
Smoking 423 (30%) 84 (15.8%) <0.001a
Alcoholism 187 (13%) 54 (10%) 0.054
Psychiatric disease 147 (10%) 45 (8%) 0.17
Solid organ transplant 0 (0%) 6 (1.1%) <0.001a
HIV 8 (0.6%) 1 (0.2%) 0.46
Outcomes
Max Marshall MOF score 4.7 (3.2 to 6.7) 5.3 (3.8 to 7.2) <0.001a
Max Denver 2 MOF score 2 (0 to 3) 2 (1 to 4) <0.001a
On ventilator, days 6 (2 to 13) 8 (3 to 16) <0.001a
Tracheostomy 308 (22%) 145 (27%) 0.019a
ICU readmission 137 (10%) 51 (10%) 0.93
Non-infectious complications 592 (42%) 277 (53%) <0.001a
Surgical site infections 202 (15%) 61 (11%) 0.09
VAP 363 (26%) 159 (30%) 0.023a
ICU length of stay, days 9 (4 to 17) 11 (5 to 20) <0.001a
Hospital length of stay, days 19 (10 to 31) 18 (9 to 30) 0.07
Complicated outcome 391 (30%) 226 (47%) <0.001a
Mortality at 28 days 54 (6.7%) 76 (15.8%) <0.001a
P-value considered significant at <0.05 designated by superscript a. Complicated outcome is defined as >14 days of persistent organ dysfunction or death. NISS,
new injury severity scale; ED, emergency department; SBP, systolic blood pressure; MOF, multiple-organ failure; VAP, ventilator-associated pneumonia.
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Table 2 Discharge disposition of young and aged trauma patients
Patient discharge disposition
Young (age <55 years) (n = 1,395) Aged (age ≥ 55 years) (n = 533)
Number (%) P-value
Home 480 (34.4%) 66 (12.4%) <0.001a
Inpatient rehabilitation 357 (25.5%) 96 (18.0%) <0.001a
LTAC 52 (3.7%) 38 (7.1%) 0.002a
Skilled nursing facility 283 (20.3%) 193 (36.2%) <0.001a
Other 43 (3.1%) 12 (2.3%) 0.36
Death (as inpatient) 180 (12.9%) 128 (24.0%) <0.001a
A P-value <0.05 was considered significant designated by superscript a. LTAC, long-term acute care facility.
Vanzant et al. Critical Care  (2015) 19:77 Page 6 of 15expression patterns in the uncomplicated cohorts at
12 hours and one day after injury (results not shown).
Therefore, further analysis of these groups was not
performed.
As our epidemiological analysis illustrated that aged
patients had a worse outcome to severe trauma, we
wished to determine if there were differences due to age
in the transcriptomic response to injury and shock,
while trying to exclude the confounders of the magni-
tude of the injury, gender, the hospital course, and treat-
ment. Thus, we compared the genome-wide expression
patterns of matched (for the variables of: complicated
outcome; gender; AIS; number of samples isolated at theTable 3 Multivariate analysis examining the association
between age and complicated outcome and mortality
after severe blunt trauma
Risk factor Odds ratio (95% CI) P-value
Complicated outcome1
New injury severity score >34 2.82 (2.26 to 3.51) <0.001
Total blood >9.5 U, 0 to 12 hours 2.72 (2.06 to 3.59) <0.001
Age ≥55, years 2.25 (1.76 to 2.89) <0.001
Lactate >6, mmol/L, 0 to 6 hours 1.82 (1.41 to 2.36) <0.001
Body mass index >28, kg/m2 1.56 (1.26 to 1.94) <0.001
ED SBP <90, mmHg 1.46 (1.16 to 1.85) <0.001
Crystalloid >12.5, L, 0 to 12 hours 1.43 (1.12 to 1.83) 0.004
Major medical comorbidity, ≥1 1.34 (1.05 to 1.72) 0.019
Mortality at 28 days2
Total Blood > 9.5 (U) 0 to 12 hours 3.91 (2.93 to 5.22) <0.001
Lactate >6, mmol/L, 0 to 6 hours 2.22 (1.67 to 2.96) <0.001
Age ≥55, years 2.12 (1.59 to 2.82) <0.001
New injury severity score >34 1.74 (1.32 to 2.29) <0.001
ED SBP <90, mmHg 1.66 (1.20 to 2.30) 0.002
1Model fit statistics: area under the curve (AUC), c = 0.748; Akaike information
criterion (AIC) = 1982; likelihood ratio test, P <0.0001). 2Model fit statistics:
AUC, c = 0.775; AIC = 1433; likelihood ratio test, P <0.0001). All risk factors were
found to be significant, defined as a P-value <0.05. Complicated outcome is
defined as >14 days of persistent organ dysfunction or death. U, units; ED,
emergency department; SBP, systolic blood pressure.same time points; and whether the patient died during
hospitalization) patients with complicated outcomes.
This revealed 3,121 probe sets (2,095 genes) that were
differentially expressed between the two age groups at
12 hours after trauma (F-test, P <0.001). Leave one out
cross-validation was used to confirm that the differences
in PMN gene expression between young and aged patients
could not be explained by chance alone (Figure 1A).
When examining the DFRs calculated for each pa-
tient’s PMN gene expression patterns over time, it was
observed that both the aged and young cohorts experi-
enced different transcriptomic responses from controls
at all measured time points. However, the aged cohort
had significantly more aberrant expression 4 days after
hospital admission than the younger complicated trauma
cohort (DFR (×103): 116 ± 54 versus 88 ± 29 (SD);
P <0.05) (Figure 1B).
Subsequently, secondary analysis was conducted on the
63 total leukocyte genes whose dysregulation is known to
predict complicated outcomes after severe trauma [8].
This demonstrated that only 51 of the 63 previously iden-
tified genes were significantly expressed in the PMNs of
both the young and aged trauma cohorts with complicated
outcomes. Therefore, only these 51 genes were used for
subsequent comparison. Analysis demonstrated differen-
tial expression over time between the aged and young
complicated trauma patients. The DFRs of these 51 genes
in the aged cohort with complicated courses, revealed that
their gene expression patterns were significantly less per-
turbed at 12 hours and 1 day after injury (DFR (×103):
1.031 ± 0.364 versus 0.776 ± 390 and 1.741 ± 0.705 versus
0. 984 ± 0.506; P <0.05). By day four after injury, the aged
patients had significantly increased alterations in their
gene expression patterns (DFR (×103): 1.549 ± 0.680 ver-
sus 1.024 ± 0.673; P <0.05) when compared to controls
and their younger counterparts (Figure 2).
Focusing on individual gene fold-changes at 12 hours
and 1 day after injury, the young cohort was noted to
have significant alterations in gene expression involved
in neutrophil chemotaxis (that is, CCR3, IL-8), increased
Figure 1 Heat map and calculated difference from distance from reference (DFR) for polymorphonuclear neutrophil (PMN) genome-wide
expression. Using a false discovery adjusted probability of <0.001 and a two-fold difference in expression, the temporal pattern of the expression
of the trauma responsive genes that differed between the matched aged (≥55 years) and young (<55 years old) trauma cohorts with complicated
outcomes, as well as healthy controls, is presented. (A) Cluster analysis of the cohorts 0.5 days after injury showed that there were 3,121 probe sets
(2,095 genes) with expression that was significant expressed among groups (F-test, P <0.001). In addition, the overall pattern of gene expression was
significantly different in each cohort, as determined by leave one out cross-validation. (B) Summary of the DFR score calculated for each patient in the
complicated aged and young cohorts at days 0.5, one and four days after injury. Analysis revealed significant differences in the DFRs at all the post
trauma time points between the two cohorts when compared to controls. In addition, the advanced age cohort had significantly more aberrant gene
expression as compared to the young patients on day 4 (Newman-Keuls multiple comparison test, *P <0.05).
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creased responses of the innate and adaptive immune
system (that is, CD24, CD44, IL4R) when compared to
controls. In addition, the young cohort had an increased
magnitude of genomic changes, as compared to those of
the aged cohort (Table 4). By day 4 post injury, the
gene-fold changes seen in the young began to trend back
toward control baseline expression, with decreased ex-
pression of pro-inflammatory genes and increased im-
mune response (antigen presentation and co-stimulatory
molecule genes). The aged cohort, however, continuedto demonstrate significant alterations in genes involved
in decreased chemotaxis of neutrophils, upregulation of
myeloid derived suppressor cells (MDSC), increased in-
flammation, and decreased response of the innate and
adaptive immune system, as compared to controls, 4
days after injury (Table 4).
Gene ontology and Biocarta DFR pathway analysis
demonstrated that complicated young trauma patients
had significantly more aberrant expression patterns (fold
change versus control baseline expression) for PMN
pathways involved in innate immunity and neutrophil
Figure 2 Calculated difference from reference (DFR) for 51 of
the 63 known genes that distinguish clinical trajectory. Using a
false discovery adjusted probability <0.001 and a twofold difference
in expression, the temporal pattern of expression of the 51 genes
that differed between the matched aged (≥55 years old) and young
(<55 years old) trauma patients with complicated outcomes, as well
as healthy controls, was analyzed and used to calculate a DFR score.
The summary of the DFR scores for the patients in each cohort at
days 0.5, 1.0 and 4.0 after traumatic injury is presented. Statistical
analysis at 0.5, one and four days revealed significant differences in
the DFRs between the young and aged. On days 0.5 and 1.0, the
expression patterns in the young complicated trauma patients were
significantly more aberrant from control to those seen in the
advanced age cohort. By day 4, the expression patterns in the aged
were found to be significantly more aberrant from controls than
those seen in the young (Newman-Keuls multiple comparison test,
*P <0.05).
Table 4 Time-dependent immunity-related gene
expression
Genes of interest over time
Gene Day 0.5 Day 1.0 Day 4.0
Aged Young Aged Young Aged Young
Neutrophil chemotaxis
CCR3 -3.1 -3.6 -3.3 -3.8 -2.7 -1.6
IL8 -4.2 -1.8 -12.7 -10.2 -22.5 -7.6
Immune-related genes/antigen presentation/co-stimulatory
molecules/increased MDSCs
ARG1 6.8 6.9 7.9 7.2 7.4 4.4
IL4R 2.9 3.5 3.2 2.7 2.7 2.4
CD24 1.9 3.4 -1 2.1 1.8 4.7
CD44 2.8 3.9 3.2 3.5
OLFM4 2.6 10.8 1.2 7.1 5.1 7.3
HERC5 -3.5 -6.3 -6.1 -9.8 -6 -4.3
IFIT1 -4.6 -8.5 -7.9 -14.6 -6.7 -4.3
IFIT2 -3.2 -5.7 -4.1 -7.2 -4.4 -2.8
IFIT3 -2.3 -3.1 -3.2 -4 -3.7 -2.8
IFIT5 -2.6 -3.9 -3.1 -3.6 -2.9 -2.4
VNN1 5.4 8 6.3 9.5 6.5 11.2
IL1R1 1.8 2 1.4 1.5 1.5 1.4
IL1R2 2.1 2 1.7 1.6 1.8 1.5
HGF 2.4 3.6 2.7 5.7 2.9 2.7
Inflammation-related peptides and proteins
CD177 13.2 21.3 23.3 30.1 18.5 22.3
HMGB1 -1.3 -1.5 -1.4 -1.2
HP 5.2 8.9 7.3 11.2 7.8 4.6
MMP8 7.6 22.4 5.9 22.6 15.1 9.8
MMP9 6.8 9.3 7.8 7.1 7.5 4.5
The table displays the fold changes of selected genes from complicated young
and aged trauma patient matched pairs. Positive numbers are indicative of
increased fold changes (as compared to controls) and negative numbers are
indicative of decreased fold changes. In the acute periods after trauma (days 0.5
and 1.0) the young cohort had greater alterations in gene fold-expression among
genes associated with increased inflammation, decreased neutrophil function
and impaired immunity as compared to baseline expression in healthy human
controls (P <0.001) than those seen in the aged. In the sub-acute period (day 4.0),
this pattern switched as the young trended toward baseline and the aged
continued to experience significantly greater alterations in individual genes from
baseline expressions. MDSC, myeloid-derived suppressor cells.
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the aged. By day 4, these patterns once again switched
and the aged displayed significantly more aberrant ex-
pression patterns compared to controls than the young
cohort (Figure 3). Additional IPA® analysis of functional
pathways revealed that on day 1 after injury, the aged
had significant further downregulation of PMN pathways
important to immunity, as compared to the young co-
hort (Figure 4).
Plasma cytokine analysis
Elderly patients with complicated outcomes had de-
creased plasma cytokine and chemokine concentrations
early after severe hemorrhage and injury, as compared
to younger patients with complicated outcomes, verify-
ing our transcriptomic analysis. The elderly had signifi-
cantly decreased circulating levels of IL-6, IL-8, IL-10,
MCP-1, and TNF-α in the acute and subacute periods
after severe trauma. No difference was noted for the
level of IP-10 (data not shown) between the young and
aged after severe injury and hemorrhage. GLM analysis
showed that these significant differences were found to
be a product of both age and time after injury for of IL-
6, IL-8, IL-10, MCP-1 and due to age alone for IL-1β
and TNF-α (P <0.05) (Figure 5).Discussion
Advanced age has been shown to be associated with
both alterations in immunologic pathways and adverse
clinical outcomes after severe trauma [26-35]. The
Trauma GG has provided a unique opportunity to
examine large amounts of clinical and outcome data. In
addition, these data were correlated to genomic data
from isolated leukocyte subpopulations in a large subset
of patients with advanced age. This analysis confirms, in
a prospective, multi-institutional cohort of severely in-
jured patients, that advanced age is an independent risk
Figure 3 Selected gene ontology pathway heat maps in complicated aged and young patients on days 0.5, 1.0 and 4.0 after severe
traumatic injury. Dark blue represents upregulation, whereas light blue represents down regulation. In complicated young patients, gene
ontology pathway analysis demonstrated that several pathways involved in innate immunity and neutrophil function (that is, antigen processing
and presentation and neutrophil chemotaxis pathways) were significantly more aberrant from controls in the acute periods (days 0.5 and 1) than
was seen in the aged. In the sub-acute period (day 4) after injury, these patterns switched. The young trended back toward baseline expression
values while the aged continued to demonstrate significantly more aberrant expression patterns in pathways involved in innate immunity and
neutrophil function (that is, neutrophil activation pathway) (Holm-Sidak, *P <0.05).
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Figure 4 Selected pathways from functional pathway analysis between complicated aged and young patients after severe traumatic
injury. Functional pathway analysis on day 1 after injury showed that complicated aged patients had significantly downregulated pathways
involved in cell survival, function, chemotaxis, immune cell trafficking and hematological system development categories. Graphs display the
category broken down into the various subcategories and their corresponding significance level (*Z-score <-2; downregulated). (A) Functional
analysis on day 1 after severe traumatic injury showed that aged patients had either an upregulation or down regulation of genes leading to a
significant overall downregulation of pathways in the cell death and survival category (that is, cell survival, cell viability, apoptosis of myeloid cell
pathways) compared to controls. Young complicated traumatic injury patients did not reach a similar significance. (B) Similarly, functional analysis
on day one showed that aged patients had either an upregulation or downregulation of genes leading to a significant overall downregulation of
pathways involved in the cellular function and maintenance category (that is, autophagy of cells, leukocyte and blood cell function and cellular
homeostasis pathways) as compared to controls. Again, complicated young trauma patients did not reach a similar significance.
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function, inpatient mortality, or significant functional
disability for those that survive to discharge. Addition-
ally, we have demonstrated that the transcriptomic and
cytokine/chemokine response to trauma that results in
complicated outcomes is age-dependent, with differential
genomic and protein expression of immunologic path-
ways after injury.
Although advances in surgical critical care have substan-
tially improved early mortality associated with trauma,many patients who survive the initial injury, especially
those who are aged, go on to succumb from complications
including MOF, secondary nosocomial infections and sep-
sis [36,37]. Despite decades of promising preclinical and
clinical investigations that have elucidated individual as-
pects of the complex pathophysiology and immunologic
disturbances present in sepsis and trauma, our under-
standing of these entities is still incomplete.
In addition, few therapies targeted towards these
mechanistic findings have been successful in improving
Figure 5 Plasma cytokine and chemokine levels in complicated aged and young patients at 12, 24, 96, 185, 336, 504 and 672 hours
after severe injury and hemorrhage. The elderly had significantly less cytokine and chemokine concentrations in their plasma after severe
blunt trauma. General linear model analysis was performed to examine the significance in relationship of age and time after injury, to the
differences seen in the concentrations cytokines and chemokines between the cohorts. Analysis of the plasma demonstrated that both age and
time had significant effects on the differences observed for the levels of IL-6, IL-8, IL-10 and MCP-1 (*model P <0.05). Model analysis of IL-1β and
TNF-α found that only age had a significant effect on the differences observed (҂P <0.05). Neither age, nor time after traumatic injury, were found
to have significant effect on the levels of IP-10 (data not shown).
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[38-40]. Since the elderly population is expanding, re-
search in this cohort has become increasingly relevant,
especially with the escalating economic and health care
burdens in our society.
In this study, we found that patients over the age of 55
years are more likely to have severe physiologic derange-
ments and increased inpatient mortality after traumatic
injury with associated hemorrhagic shock when com-
pared to their younger, similarly injured counterparts.
Perhaps most importantly, aged patients who survive the
initial insult are more likely to have a prolonged and
complicated clinical recovery. These patients then have
an increased risk of functional disability at discharge, if
one uses their discharge disposition to such places as
nursing homes and long-term acute care facilities as a
surrogate of their functional status. We believe a compli-
cated clinical course, characterized by an extended ICU
LOS and persistent organ dysfunction, are early clinical
predictors for patients at risk of developing the persist-
ent inflammation, immunosuppression and catabolism
syndrome (PICS) and dismal long-term outpatient out-
comes [41].As previously demonstrated in young human patients,
severe traumatic injury is associated with a genomic
storm in total circulating leukocytes with concurrent
SIRS and CARS responses [6]. In our analysis of the
PMN transcriptome and its response to injury in young
and aged trauma patients, we found the genomic re-
sponse patterns in these two populations to be unique.
In the acute period after trauma (12 to 24 hours after in-
jury), the PMNs from the young patients display a more
aberrant transcriptomic response (increased magnitude)
than those with advanced age for both the entire gen-
ome and when looking at 51 of the 63 genes previously
demonstrated to be predictive of complicated outcomes
[8]. This is consistent with immuno-senescence, a state
of profound age-associated changes in the immune sys-
tem, making the aged less capable of mounting an effect-
ive immune response [42,43]. This pattern appears to
switch in the sub-acute period (day 4 after injury) with
continued aberrant genomic expression in the aged co-
hort’s transcriptome, unlike the young, who appear to
trend back towards a homeostatic baseline.
Authors have previously argued that age-related im-
mune dysfunction is due to an exacerbated response in
Figure 6 Our depiction of the summary of the differences in
immune response to severe traumatic injury between the
young (<55 years old) and the aged (≥55 years old) who
experience complicated clinical outcomes. In the acute period
(days 0.5 and 1) after trauma, the aged demonstrate a diminished
immune response consistent with immuno-senescence as compared
to their younger counterparts. This is followed by continued
dysregulation in the advanced age patients as the young trend
toward controls by day 4 after injury. In the acute and sub-acute
periods after injury, the complicated young and aged trauma
patients demonstrate unique genomic expression patterns that
are temporal in nature, illustrating that their biologic response to
severe injury is different, although they had similar outcomes.
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infectious inflammation [44]. For example, in models of
intra-abdominal sepsis, the inflammatory response (as
measured by cytokine levels of TNF-α, IL-6, IL-10 and
MCP-1) of aged mice was found to be increased as com-
pared to young mice [31]. However, we have published
data from murine models to indicate the contrary [10].
Our human analysis of plasma from elderly and young
patients with blunt trauma disproves this as well
(Figure 5). Additionally, the transcriptomic analysis de-
scribed in this study indicates that the early PMN re-
sponse to severe injury and hemorrhagic shock in
humans of advanced age is consistent with our murine
data, showing that advanced age subjects are unable to
mount a robust and effective acute inflammatory re-
sponse at the level of the transcriptome. This is then
followed by persistent aberrant genomic expression pat-
terns that fail to return to baseline in the sub-acute
period, suggesting a prolonged state of low-level inflam-
mation (Figure 6).
These findings support our previously described model
of PICS [45]. Although inflammaging, an age-related in-
crease in systemic chronic inflammation exists [46],elderly patients, at least at the transcriptomic level, do
not have a more exacerbated response to injury as com-
pared to their younger cohorts. In fact, their ability to
mount an acute innate immune response is relatively
subdued in the acute period. A better comprehension of
this phenomenon will be vital as we work towards pre-
dictive models of outcome and therapeutic interventions
for the injured aged patient population.
Although it is difficult to examine the transcriptomic
response related to catabolism in PMNs or other leuko-
cytes isolated from trauma patients, we believe the genes
that are significantly altered from baseline expression
levels in the aged after trauma do represent the other
criteria for PICS: chronic low grade inflammation and
immunosuppression [41,45]. As compared to their youn-
ger counterparts (Table 4), PMNs from aged patients
who had complicated outcomes after severe trauma and
hemorrhage revealed continued downregulation of genes
required for appropriate leukocyte function (e.g. CCR3,
IL8) or continued increased expression of inflammatory
genes (e.g. HP, MMP8, MMP). Although all the genes
related to immunity do not follow this pattern, again
illustrating the complexity of the leukocyte response to
inflammation, we believe that much of the focus of
future critical care research will need to be in the PICS
phenotype, especially regarding the treatment of the
elderly [45].
One of the most interesting genes, from the perspec-
tive of PICS and potential interventions, is arginase 1
(Table 4). Although in the acute phase this enzyme plays
an important role in myeloid cell antibacterial activity,
prolonged expression is associated with the presence of
MDSCs [41,45,47]. These cells have suboptimal innate
immune responses and are capable of inducing adaptive
immune suppression [47]. In the subacute period after
trauma, young patients with complicated outcomes be-
ing to return to baseline line expression levels of ARG1
(Table 4) while the elderly continue to have increased
transcriptomic expression. It is possible that dysfunc-
tional emergency myelopoiesis in the elderly could lead
to increased and prolonged production of MDSCs after
inflammation in the elderly, in part explaining their
worsening morbidity and mortality after trauma and
sepsis. Further study of these cells may reveal them to
be a target for immunotherapy to specifically improve
outcomes in this population [26-35,41,45,47].
The primary potential weakness of this study is that it
is difficult to conclude whether the failure of the PMN
transcriptome to return to baseline in the aged is either
the result of more frequent complicated outcomes or
their cause. One explanation for the continued aberra-
tion is the increased frequency of secondary infections
and ongoing multiple organ injury. Conversely, the
aberrant PMN transcriptome may reflect a circulating
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munosuppressed, and it is this aberrant state that con-
tributes to the increased frequency and severity of
secondary infections. Although it is likely that both ex-
planations are partially true, interventional studies in
animal models and subsequent human clinical trials will
be required to fully answer this important question. Sec-
ond, having an elderly healthy population for compari-
son would have been beneficial to the study, but was not
essential for the evaluation and conclusions. Finally, a
higher compliance rate with the clinical SOPs at the
various institutions would have been more optimal for
this type of study, though over the study period the ma-
jority of the SOPs had a compliance rate >69%, and
upon review, the application of these SOPs was found to
be associated with improved patient mortality during the
study period [15]. Although compliance improved over
time with repeated audits, there was variable compliance
depending upon the bundle audited.
Decades of promising preclinical and clinical investi-
gations have elucidated individual aspects of the com-
plex pathophysiology present after trauma, but our
understanding of these entities is still incomplete, and
few successful therapies have been introduced to any
age group [48,49]. The overall failure of the single medi-
ator or cytokine approach to treat sepsis is actually due,
in large part, to an underestimation of the magnitude
and diversity of the host response to either severe
trauma or infection. Human blunt trauma produces
what has been termed a genomic storm in which expres-
sion of over 75% of the human leukocyte transcriptome
is effected [6]. This becomes even more problematic in
the aged population, as their leukocyte genomic re-
sponse is different than that of their younger counter-
parts, thus indicating that interventional approaches
may need to be both multiplex and tailored to different
age groups.
Conclusions
Advanced age is a risk factor for increased morbidity
and mortality in many disease processes [26-35]. As the
general population’s age increases, this will become more
relevant to trauma, which has traditionally been consid-
ered more pertinent to younger cohorts. We have found
that advanced age is one of the greatest predictors of
poor clinical outcomes after severe blunt traumatic in-
jury with hemorrhagic shock, and that advanced aging is
associated with a unique genomic expression pattern in
circulating neutrophils (Figure 6). The latter challenges
many conventionally held beliefs about the elderly re-
sponse to severe injury, and will have to be taken into
consideration when creating individualized prediction
models and therapeutic targets tailored to this high-risk
cohort.Key messages
 After severe trauma, advanced age is associated with
more severe organ failure, infectious complications,
ventilator days, and ICU LOS, as well an increased
likelihood of being discharged to skilled nursing or
long-term care facilities.
 Advanced age is an independent predictor of a
complicated recovery and 28-day mortality after
severe injury and hemorrhage, thus impacting both
traditionally analyzed short-term mortality, as well
as more recently proposed measures of long-term
disposition
 Acutely after trauma, blood neutrophil genome-wide
expression analysis of the aged reveals an attenuated
transcriptomic response as compared to the young.
 Subacutely after severe injury and hemorrhage, these
advanced age patients demonstrate gene expression
changes consistent with simultaneous, persistent
pro-inflammatory and immunosuppressive states.
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